Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes

被引:115
作者
Oddoze, C
Morange, S
Portugal, H
Berland, Y
Dussol, B
机构
[1] Hop Conception, Serv Nephrol, F-13385 Marseille 05, France
[2] Hop St Marguerite, Cent Lab, Marseille, France
[3] Hop St Marguerite, Ctr Invest Clin, Marseille, France
关键词
cystatin C; beta(2)-microglobulin; creatinine; glomerular filtration rate (GFR); diabetes;
D O I
10.1053/ajkd.2001.26096
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
This study evaluated serum cystatin C as a potential new marker of glomerular filtration rate (GFR) in 49 patients who had steady-state diabetes with early renal impairment. We determined the correlation between GFR measured by chromium 51-labeled EDTA and levels of serum cystatin C, serum creatinine, serum beta (2)-microglobulin, endogenous creatinine clearance, and Cockcroft formula. Sensitivity and specificity for the diagnosis of renal failure, defined as a GFR less than either 80 or 60 mL/min/1.73 m(2), were calculated by receiver operating characteristic (ROC) curves for creatinine, cystatin C, and beta (2)-microglobulin. Finally, we compared mean values of these three serum parameters in patients grouped according to GFR using the two definitions of renal failure. Correlation coefficients with GFR were -0.77 for serum creatinine level, -0.65 for serum cystatin C level, -0.71 for serum beta (2)-microglobulin level, +0.56 for endogenous creatinine clearance, and +0.69 for Cockcroft formula (all P < 0.001). With a cutoff value of 60 mL/min/1.73 m(2), areas under the ROC curve were 0.972 for beta(2)-microglobulin, 0.925 for cystatin C, and 0.916 for creatinine levels. With a cutoff value of 80 mL/min/1.73 m(2), these were 0.838 for beta (2)-microglobulin, 0.780 for cystatin C, and 0.905 for creatinine levels (P = not significant between parameters). These results were not altered after the exclusion of patients (n = 8) with a serum creatinine level greater than 1.41 mg/dL. When patients were classified into three groups according to GFR (group 1, >80 mL/min/1.73 m(2); group 2,60 to 80 mL/min/1.73 m(2); group 3, <60 mL/min/1.73 m(2)), mean values of serum parameters in the three groups were statistically different (P < 0.0001) except between groups 1 and 2 for cystatin C and beta (2)-microglobulin. With patients classified into two groups (GFR > or < 80 mL/min/1.73 m(2)), mean values for each parameter were statistically different (P < 0.001). Sensitivity, specificity, and positive and negative predictive values for serum creatinine and serum cystatin C levels were very close for both definitions of renal failure. Serum cystatin C Is not better than serum creatinine or serum beta (2)-microglobulin levels for estimating GFR in patients with steady-state diabetes using ROC curves or other validation tests. (C) 2001 by the National Kidney Foundation, Inc.
引用
收藏
页码:310 / 316
页数:7
相关论文
共 25 条
  • [11] Cystatin C: Efficacy as screening test for reduced glomerular filtration rate
    Herget-Rosenthal, S
    Trabold, S
    Pietruck, F
    Holtmann, M
    Philipp, T
    Kribben, A
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2000, 20 (02) : 97 - 102
  • [12] KAMPMANN J, 1974, ACTA MED SCAND, V196, P517
  • [13] KNULMAN JT, 1988, CLIN CHEM, V34, P135
  • [14] LEVEY AS, 1988, ANNU REV MED, V39, P465, DOI 10.1146/annurev.med.39.1.465
  • [15] Validity of rapid estimation of glomerular filtration rate in type 2 diabetic patients with normal renal function
    Nielsen, S
    Rehling, M
    Schmitz, A
    Mogensen, CE
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (03) : 615 - 619
  • [16] Reference intervals for the glomerular filtration rate and cell-proliferation markers: serum cystatin C and serum beta(2)microglobulin/cystatin C-ratio
    Norlund, L
    Fex, G
    Lanke, J
    VonSchenck, H
    Nilsson, JE
    Leksell, H
    Grubb, A
    [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1997, 57 (06) : 463 - 470
  • [17] Rapid and accurate assessment of glomerular filtration rate in patients with renal transplants using serum cystatin C
    Risch, L
    Blumberg, A
    Huber, A
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (08) : 1991 - 1996
  • [18] Determination of serum cystatin C in patients with essential hypertension
    Seco, ML
    Rus, A
    Sierra, M
    Caballero, M
    Borque, L
    [J]. NEPHRON, 1999, 81 (04) : 446 - 447
  • [19] LIMITATIONS OF CREATININE AS A FILTRATION MARKER IN GLOMERULOPATHIC PATIENTS
    SHEMESH, O
    GOLBETZ, H
    KRISS, JP
    MYERS, BD
    [J]. KIDNEY INTERNATIONAL, 1985, 28 (05) : 830 - 838
  • [20] SPENCER K, 1986, ANN CLIN BIOCHEM, V23, P1